Simple Cysts Found by Ultrasound Don’t Require Action
(November 16, 2018) JAMA Internal Medicine recently published an eleven year study of over 72,000 women that found having a simple ovarian cyst does not increase one’s risk of ovarian … Continued
News
For Some, Statin Use Can Decrease the Risk of Ovarian Cancer
(November 13, 2018) The International Journal of Cancer recently published a study that explored the use of statins, which reduces one’s lipids, and their effect on ovarian cancer risk. After … Continued
World Ovarian Cancer Coalition Releases Every Woman Study Report
(October 25, 2018) Through a series of surveys, interviews, and literature reviews the World Ovarian Cancer Coalition produced a report that detailed their findings and recommendations. Their study spanned the … Continued
Maintenance olaparib Improves Progression-Free Survival in Phase III Clinical Trial
(October 23, 2018) Olaparib, or Lynparza, was shown to increase progression-free survival (PFS) by almost three years in an ongoing trial known as SOLO-1. The women in the study are … Continued
OCRA Research Shows How Cancer Cells Negatively Impact the Communication between the Ovary and Fallopian Tube
(October 22, 2018) A team at the University of Illinois at Chicago, including OCRA grantee Matthew Dean, PhD, recently discovered the role that cancer cells have on their immediate environment. … Continued
Study Looks at Long-term Survival Trends in Ovarian Cancer
(October 19, 2018) A retroactive study using SEER, or Surveillance, Epidemiology, and End Results, looked at the trends in ovarian cancer from 1983 to 2012. In almost 3 decades, the … Continued
Kunle Odunsi, MD, PhD, Elected to National Academy of Medicine
(October 18, 2018) Longtime OCRA Scientific Advisory Committee member and former grantee Kunle Odunsi, MD, PhD, has been elected to the National Academy of Medicine—a distinguished lifetime designation that is … Continued
OCRA Funded Research Reveals Immune Suppression in Ovarian Cancer
(October 15, 2018) This month in Nature, researchers from Weill Cornell published a study that helps to explain why the body’s natural immune response struggles to fight back against ovarian … Continued
Certain Kinds of Contemporary Birth Control Pills Shown to Reduce Ovarian Cancer Risk
(October 11, 2018) The BMJ recently published a study from Denmark about the effect that newer birth control pills have on ovarian cancer risk. Researchers focused on two kinds of … Continued
Baby Aspirin Associated with Lower Risk of Ovarian Cancer
(October 9, 2018) A study, published in JAMA Oncology, followed about 200,000 women over the course of 25 years in order to track their use of analgesics. A little over … Continued
OCRA Funded Study Increased Genetic Counseling Referrals for Epithelial Ovarian Cancer Patients
(October 2, 2018) A study by the Mayo Clinic earlier this year aimed to increase the amount of genetic counseling referrals to epithelial ovarian cancer patients by supplying patients with … Continued
Super September New York City
(October 1) OCRA’s inaugural Super September shopping event took place on September 27-28 at Pier 17 in Manhattan. Guests enjoyed discount designer shopping, a special musical performance from the hit … Continued